The Controversial Effect of Antibiotics on Methicillin-Sensitive


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
14 Nov 2023
Historique:
received: 04 10 2023
revised: 06 11 2023
accepted: 09 11 2023
medline: 27 11 2023
pubmed: 25 11 2023
entrez: 25 11 2023
Statut: epublish

Résumé

Methicillin-sensitive

Identifiants

pubmed: 38003500
pii: ijms242216308
doi: 10.3390/ijms242216308
pmc: PMC10671744
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Methicillin Q91FH1328A
Rifampin VJT6J7R4TR
beta-Lactams 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : 444711651, RTG 2723 Materials-Microbes-Microenvironments (M-M-M: Projects A and D)
Organisme : Clinician Scientist"-program of the Interdisciplinary Center for Clinical Research, Jena University Hospital
ID : Year 2021

Références

Rev Infect Dis. 1983 Jul-Aug;5 Suppl 3:S407-11
pubmed: 6356275
Biochim Biophys Acta Biomembr. 2021 Jun 1;1863(6):183597
pubmed: 33652005
Essays Biochem. 2017 Mar 3;61(1):71-79
pubmed: 28258231
Clin Infect Dis. 1998 Sep;27(3):419-22
pubmed: 9770133
Springerplus. 2015 Nov 04;4:672
pubmed: 26558175
Front Microbiol. 2020 May 21;11:1028
pubmed: 32508801
RSC Med Chem. 2021 Aug 4;12(10):1623-1639
pubmed: 34778765
Clin Microbiol Infect. 2019 Jul;25(7):818-827
pubmed: 30928559
Bioessays. 2014 Oct;36(10):991-6
pubmed: 25100240
Curr Protoc Microbiol. 2005 Jul;Chapter 1:Unit 1B.1
pubmed: 18770545
Nat Med. 2023 Oct;29(10):2518-2525
pubmed: 37783969
Annu Rev Microbiol. 1995;49:711-45
pubmed: 8561477
Antibiotics (Basel). 2023 Sep 14;12(9):
pubmed: 37760742
Mol Microbiol. 2017 May;104(3):365-376
pubmed: 28142193
J Infect Dis. 2010 Oct 1;202(7):1031-40
pubmed: 20715929
Pharmaceutics. 2022 Jan 27;14(2):
pubmed: 35214028
Immunity. 2009 Jan 16;30(1):108-19
pubmed: 19144317
Nat Rev Microbiol. 2007 Jan;5(1):48-56
pubmed: 17143318
Clin Infect Dis. 2021 May 4;72(9):1517-1525
pubmed: 32725216
J Infect Chemother. 2020 Feb;26(2):162-169
pubmed: 31676266
J Antimicrob Chemother. 2003 Jul;52(1):1
pubmed: 12805255
Clin Microbiol Rev. 2015 Jul;28(3):603-61
pubmed: 26016486
PLoS One. 2013 Oct 18;8(10):e77614
pubmed: 24204894
Colloids Surf B Biointerfaces. 2013 Nov 1;111:747-54
pubmed: 23934235
J Infect Dis. 1996 Mar;173(3):739-42
pubmed: 8627043
Pathog Dis. 2023 Jan 17;81:
pubmed: 37422444
Int J Antimicrob Agents. 2008 Jun;31(6):507-10
pubmed: 18180148
J Antimicrob Chemother. 2020 Aug 1;75(8):2282-2290
pubmed: 32355950
Antibiotics (Basel). 2019 Dec 03;8(4):
pubmed: 31816949
Front Cell Infect Microbiol. 2014 Oct 21;4:141
pubmed: 25374845
Clin Microbiol Rev. 2010 Jan;23(1):14-34
pubmed: 20065324
Front Cell Infect Microbiol. 2014 Dec 23;4:178
pubmed: 25566513
Front Microbiol. 2019 Jan 28;10:40
pubmed: 30745897
West J Emerg Med. 2019 May;20(3):438-442
pubmed: 31123543
Annu Rev Microbiol. 2013;67:313-36
pubmed: 24024634
Nat Rev Microbiol. 2006 Apr;4(4):295-305
pubmed: 16541137
Antimicrob Resist Infect Control. 2020 Aug 17;9(1):135
pubmed: 32807239
Proc Natl Acad Sci U S A. 1983 Jun;80(12):3734-7
pubmed: 6407019
Front Cell Infect Microbiol. 2022 Feb 25;12:850030
pubmed: 35281447
J Clin Microbiol. 2014 Feb;52(2):467-74
pubmed: 24478475
Antibiotics (Basel). 2023 Feb 17;12(2):
pubmed: 36830316
Open Forum Infect Dis. 2022 Nov 30;9(12):ofac653
pubmed: 36589483
Front Cell Infect Microbiol. 2019 Oct 22;9:363
pubmed: 31696062
Front Med (Lausanne). 2021 Mar 05;7:616524
pubmed: 33748151
J Antimicrob Chemother. 2016 Feb;71(2):438-48
pubmed: 26589581
Antimicrob Agents Chemother. 2022 Apr 19;66(4):e0227021
pubmed: 35266822
Infect Immun. 2014 May;82(5):2125-34
pubmed: 24614654
Infection. 1992 Nov-Dec;20(6):350-4
pubmed: 1293056
Sci Rep. 2018 Nov 22;8(1):17247
pubmed: 30467352
Infect Genet Evol. 2014 Jan;21:515-22
pubmed: 23722021
Antimicrob Agents Chemother. 2015 Apr;59(4):2029-36
pubmed: 25605365
Int J Med Microbiol. 2018 Aug;308(6):607-624
pubmed: 29217333
Rev Infect Dis. 1983 Jul-Aug;5 Suppl 3:S463-7
pubmed: 6356278
Pharmacotherapy. 2023 Aug;43(8):816-832
pubmed: 37133439
Clin Microbiol Infect. 2022 Jul;28(7):1026.e7-1026.e11
pubmed: 35358683

Auteurs

Valeria C J Hackemann (VCJ)

Institute for Medical Microbiology, Jena University Hospital, 07747 Jena, Germany.

Stefan Hagel (S)

Institute of Infectious Diseases and Infection Control, Jena University Hospital, 07747 Jena, Germany.

Klaus D Jandt (KD)

Otto Schott Institute of Materials Research (OSIM), Friedrich Schiller University Jena, 07743 Jena, Germany.
Jena School for Microbial Communication (JSMC), 07743 Jena, Germany.

Jürgen Rödel (J)

Institute for Medical Microbiology, Jena University Hospital, 07747 Jena, Germany.

Bettina Löffler (B)

Institute for Medical Microbiology, Jena University Hospital, 07747 Jena, Germany.

Lorena Tuchscherr (L)

Institute for Medical Microbiology, Jena University Hospital, 07747 Jena, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH